X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (899) 899
Publication (60) 60
Newsletter (41) 41
Newspaper Article (21) 21
Book Review (16) 16
Book Chapter (9) 9
Conference Proceeding (2) 2
Dissertation (2) 2
Magazine Article (2) 2
Trade Publication Article (2) 2
Transcript (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lanreotide (669) 669
humans (526) 526
somatostatin - analogs & derivatives (351) 351
octreotide (328) 328
index medicus (289) 289
endocrinology & metabolism (288) 288
male (288) 288
female (262) 262
acromegaly (251) 251
somatostatin - therapeutic use (245) 245
middle aged (238) 238
adult (215) 215
acromegaly - drug therapy (185) 185
somatostatin (179) 179
aged (175) 175
peptides, cyclic - therapeutic use (166) 166
octreotide - therapeutic use (151) 151
oncology (138) 138
neuroendocrine tumors (131) 131
somatostatin analogs (130) 130
treatment outcome (127) 127
therapy (124) 124
medicine & public health (122) 122
management (118) 118
tumors (115) 115
slow-release lanreotide (105) 105
somatostatin - administration & dosage (100) 100
antineoplastic agents - therapeutic use (97) 97
follow-up (97) 97
growth-hormone (96) 96
efficacy (94) 94
care and treatment (91) 91
neuroendocrine tumors - drug therapy (87) 87
pharmacology & pharmacy (85) 85
peptides, cyclic - administration & dosage (82) 82
somatostatin - adverse effects (77) 77
cancer (76) 76
somatostatin analogues (76) 76
diagnosis (74) 74
gastroenterology & hepatology (74) 74
surgery (74) 74
diabetes (72) 72
antineoplastic agents, hormonal - therapeutic use (68) 68
endocrinology (68) 68
igf-i (68) 68
aged, 80 and over (65) 65
long-term treatment (65) 65
somatostatin analog (64) 64
insulin-like growth factor i - metabolism (63) 63
transsphenoidal surgery (63) 63
peptides, cyclic - adverse effects (62) 62
research (61) 61
acromegaly - blood (60) 60
delayed-action preparations (60) 60
human growth hormone - blood (60) 60
secreting pituitary-adenomas (60) 60
pegvisomant (58) 58
growth hormone (57) 57
growth-factor-i (57) 57
lanreotide autogel (56) 56
analysis (53) 53
quality of life (51) 51
expression (50) 50
multicenter (50) 50
somatostatin analog lanreotide (50) 50
somatostatin - pharmacology (49) 49
acromegaly - surgery (47) 47
pancreatic neoplasms - drug therapy (47) 47
animals (46) 46
insulin-like growth factor i - analysis (46) 46
pituitary neoplasms - drug therapy (46) 46
somatotropin (46) 46
metastasis (45) 45
prospective studies (45) 45
medicine, general & internal (44) 44
octreotide - administration & dosage (44) 44
retrospective studies (44) 44
adenoma - drug therapy (43) 43
internal medicine (43) 43
pasireotide (42) 42
patients (42) 42
health aspects (41) 41
neuroendocrine tumor (41) 41
radiotherapy (40) 40
survival (40) 40
tumor shrinkage (40) 40
chemotherapy (39) 39
drug therapy (39) 39
octreotide lar (39) 39
receptors, somatostatin - metabolism (39) 39
somatostatin analogue (39) 39
carcinoid (37) 37
long-acting formulation (37) 37
octreotide-lar (37) 37
peptides, cyclic - pharmacology (37) 37
acromegalic patients (36) 36
acromegaly - therapy (36) 36
antineoplastic agents - administration & dosage (36) 36
everolimus (36) 36
octreotide - adverse effects (36) 36
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (907) 907
French (22) 22
Spanish (12) 12
German (9) 9
Korean (8) 8
Czech (3) 3
Japanese (3) 3
Polish (3) 3
Chinese (2) 2
Hungarian (2) 2
Italian (2) 2
Portuguese (1) 1
Russian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC Cancer, ISSN 1471-2407, 09/2013, Volume 13, Issue 1, pp. 427 - 427
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 2014, Volume 11, Issue 9, pp. 501 - 501
Journal Article
Nature Reviews Endocrinology, ISSN 1759-5029, 10/2014, Volume 10, Issue 10, pp. 577 - 577
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 08/2019, Volume 30, Issue 8, pp. 1513 - 1521
BACKGROUND: The formation and growth of cysts in kidneys, and often liver, in autosomal dominant polycystic kidney disease (ADPKD) cause progressive increases... 
CONSORTIUM | UROLOGY & NEPHROLOGY | DIPAK 1 | PROGRESSION | LANREOTIDE
Journal Article
British Journal of Cancer, ISSN 0007-0920, 12/2016, Volume 115, Issue 12, pp. 1540 - 1547
Neuroendocrine tumours (NET) overexpress somatostatin receptors (SSTR) that can be targeted for therapy. Somatostatin receptor expression is routinely measured... 
Receptors, Somatostatin - blood | Neuroendocrine Tumors - blood | Humans | somatostatin receptor | neuroendocrine | CTC | Molecular Diagnostics | lanreotide | CellSearch
Journal Article
Journal Article
Nanomedicine: Nanotechnology, Biology, and Medicine, ISSN 1549-9634, 10/2019, Volume 21, p. 102042
Targeted, biocompatible, and synergistic “all in one” systems should be designed to combat the heterogeneity of cancer. In this study, we constructed a dual... 
Lanreotide | Somatostatin receptors | Copper sulfide | Nanoconstruct | Docetaxel
Journal Article
Cancer, ISSN 0008-543X, 11/2006, Volume 107, Issue 10, pp. 2474 - 2481
Journal Article
Expert Opinion on Drug Safety, ISSN 1474-0338, 01/2019, Volume 18, Issue 1, pp. 1 - 10
Introduction: Lanreotide autogel is a synthetic somatostatin analogue which has been FDA and EMA approved for unresectable, well to moderately differentiated,... 
lanreotide | Gastroenteropancreatic neuroendocrine tumors (GEP-NET) | somatostatin | OCTREOTIDE | EFFICACY | LONG-ACTING FORMULATION | SOMATOSTATIN ANALOG LANREOTIDE | CARCINOID-SYNDROME | PHARMACOLOGY & PHARMACY | AUTOGEL | PATIENT | RECEPTORS | ANTAGONISTS | EXPRESSION
Journal Article
ANNALS OF SURGERY, ISSN 0003-4932, 06/2008, Volume 247, Issue 6, pp. 1029 - 1035
Purpose: Minimally invasive therapies such as transarterial chemo-embolization and radiofrequency ablation are used for hepatic metastatic neuroendocrine tumor... 
SURVIVAL | SURGERY | Y-90-DOTA-LANREOTIDE | HEPATIC METASTASES | HEPATOCELLULAR-CARCINOMA | CHEMOEMBOLIZATION | MICROSPHERES |